Psychemedics Corp (PMD): Earnings per share for the last twelve months

Corporate company logo of Psychemedics (PMD)

Net income per share dynamics confirm the resilience of Psychemedics (PMD), where the metric reached -0.51. The business relies on proprietary tests integrated into B2B compliance. High prestige and unique methodologies enable the company to attract leading toxicologists. Stability is maintained by low turnover among hair analysis experts, which eliminates personnel shortages.

PMD Psychemedics Earnings per one share for the last 12 months (07/04/2022 - 12/21/2024)
Flagship merchandise of Psychemedics Corp.

For Psychemedics (PMD), a leader in high-precision hair analysis, the trailing 12-month net profit per share chart reflects the actual monetization efficiency of its diagnostic tools. This indicator is calculated by dividing the total annual net income by the total number of shares. The metric demonstrates the actual return on a single share of capital, stripped of one-off factors. It is critical for investors to distinguish organic profit growth from an artificial inflation of EPS through share buybacks. A stable trend confirms the resilience of the business model within the law enforcement testing segment.

Competing companies

Agilent Technologies - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters questdiagnostics.com DGX|Illumina (ILMN) - Earnings per share for the last twelve months|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PerkinElmer|Bio-Rad Corp - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Anbio Biotechnology (NNNN)|Net earnings per share for the last four quarters soterahealth.com|QuidelOrtho Corporation - Net earnings per share for the last 12 months|OPKO Health Inc (OPK) - Net earnings per one share for the last twelve months|CareDx Health - Net earnings per share (EPS TTM)|Maravai (MRVI) - Net earnings per share for the last 12 months|FLGT: Net earnings per share (EPS TTM)|fluidigm.com - Earnings per share for the trailing year|CTKB (Cytek Biosciences) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months OraSure Technologies, Inc. OSUR|Earnings per share for the last twelve months Exagen Inc. (XGN)|Net earnings per share for the last 12 months MDxHealth, Inc. MDXH|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc.)|Prenetics Global Limited (PRE) - Net earnings per one share for the last twelve months|Insight Molecular - Net earnings per share (EPS TTM)|TRIB (Trinity Biotech plc) - Earnings per share for the last 12 months|PRPH: Net earnings per share (EPS TTM)|AIMD - Net earnings per share for the last four quarters|CODX (Co-Diagnostics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months heartsciences.com (HSCS)|Earnings per share for the last twelve months Biomerica (BMRA)|Net earnings per share for the last four quarters cardiodiagnosticsinc.com|Earnings per share for the last twelve months Onconetix Corp ONCO|VRAX (Virax Biolabs Corp) - Earnings per one share for the last 12 months|BJDX - Earnings per share for the last twelve months|aspirawh.com (AWH) - Net earnings per share for the last 12 months|AXDX: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CNTG|Earnings per share for the last twelve months Enzo Biochem Inc.|Net earnings per share for the last 12 months Fresh2 (FRES)|Net earnings per share (EPS TTM) GENE|ME - Net earnings per one share for the last twelve months